Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.64
-0.28 (-0.97%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
March 05, 2024
From
Pfizer Inc.
Via
Business Wire
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities.
Via
InvestorPlace
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Monday Trading
March 04, 2024
Via
Investor Brand Network
Exposures
COVID-19
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
March 04, 2024
The Biden administration wants insurers to cover preventive care, facing opposition from businesses led by Braidwood Management.
Via
Benzinga
1 S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
March 04, 2024
The picture for this stock might look bleak, but appearances can be deceiving.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Is Novavax a Buy Now?
March 04, 2024
The stock has dropped 98% over the past three years.
Via
The Motley Fool
Analyst Scoreboard: 9 Ratings For Pfizer
March 01, 2024
Via
Benzinga
This Is What Whales Are Betting On Pfizer
February 27, 2024
Via
Benzinga
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screaming Buys in March
March 04, 2024
These high-octane income stocks, which sport a scorching-hot average yield of 8.84%, can fatten the wallets of patient investors.
Via
The Motley Fool
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
March 04, 2024
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range.
Via
Investor's Business Daily
BNTX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
March 03, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
BNTX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
March 03, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Plan Ahead! 7 Stocks to Buy Before Any Market Downturn Occurs
March 03, 2024
While red ink in the broader equities space could hurt most entities, these stocks to buy for a market downturn might be resilient.
Via
InvestorPlace
3 Volatility-Busting, Low-Beta Stocks to Grab Now
March 03, 2024
These are the undervalued low-beta stocks to buy as they represent blue-chip names with robust cash flow outlook.
Via
InvestorPlace
1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
March 03, 2024
Investors are so worried about a one-off situation that they're looking right past the bigger bullish picture.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Hot on the Hedge Funds’ Trail: 3 Stocks Worth Your Bet?
March 02, 2024
With a 7.1% Q4 leap, hedge fund stocks underscore their role as incredible bets in a well-rounded portfolio.
Via
InvestorPlace
BNTX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
March 01, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
BNTX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
March 01, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
3 Overhyped Stocks Every Smart Investor Should Ignore
March 01, 2024
Learn why smart investors avoid overhyped stocks, highlighting three companies facing significant challenges in today's volatile market.
Via
InvestorPlace
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
February 29, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds
February 29, 2024
Pfizer reports strong 77.8% efficacy for Abrysvo vaccine against RSV in adults 60+. Durable 88.9% efficacy after two seasons. Consistent protection for RSV A and B. No new adverse events. FY2023 sales...
Via
Benzinga
BNTX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
February 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
BNTX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
February 29, 2024
WHY: NEW YORK, NY - (NewMediaWire) - February 29, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
February 29, 2024
From
Pfizer Inc.
Via
Business Wire
3 Starter Long-Term Stocks Every New Investor Should Own
February 28, 2024
These three long-term stocks for new investors provide a solid foundation, harmonizing risk with rewarding prospects for the long haul.
Via
InvestorPlace
3 Forgotten Dividend Stocks With a Yield of Over 5%
February 28, 2024
These are the undervalued dividend stocks to buy as they represent fundamentally strong companies poised for accelerated growth.
Via
InvestorPlace
7 Dividend Stocks to Buy to Secure Steady Income
February 28, 2024
Unlock financial growth with 7 standout dividend stocks in real estate, industrial, pharma, and telecom sectors for long-term success.
Via
InvestorPlace
3 Overextended Stocks That Need to Slash Their Dividends ASAP
February 27, 2024
The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big.
Via
InvestorPlace
Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst
February 27, 2024
Income investors can enjoy the nearly 6% dividend yield even if growth doesn't return.
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.